Why Newlink Genetics Shares Fell 10.3% Today

After reporting that a mid-stage clinical trial stumbled, NewLink Genetics Corporation (NASDAQ: NLNK) shares lost 10.3% of their value today.Last year, attention shifted to NewLink's IDO-inhibiting cancer drug pipeline after its once-promising algenpantucel-L failed to achieve its primary endpoint in phase 3 trials.IMAGE SOURCE: GETTY IMAGES.Continue reading

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News